logo
Plus   Neg
Share
Email

Centamin Advises Shareholders To Take No Action On Possible Offer By Endeavour

Responding to the announcement made by Endeavour Mining Corp., the Board of Centamin plc (CELTF.PK,CEY.L,CEE.TO), said it has reviewed the proposal with its financial and legal advisers and believes that the terms of the proposal provide comparatively greater benefit to Endeavour's shareholders, and do not adequately reflect the contribution that Centamin would make to the merged entity. Therefore, the Board has unanimously rejected the proposal.

The Board of Centamin plc strongly advised its shareholders to take no action in respect of the proposal.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL.
Follow RTT